Total Utang marang Modal Elutia (ELUT)

Elutia Inc. (ELUT) - logo korporat

Bio-implant developer Elutia Inc. (ELUT) is facing logistical disruptions in Asia and international certification challenges. Simultaneously, the company is implementing AI-driven quality control and robotic CNC lines. This chart reflects a total debt-to-equity ratio of 0.70. While the business relies on sophisticated technologies, it faces risks from pressure by corporate behemoths and budget innovations in tissue engineering.

ELUT: Rasio Utang marang Ekuitas elutia.com 21.02.2024 - 29.10.2026

Rincian analitis perusahaan Elutia Inc.

- rega lan prakiraan konsensus rega:
Bagan rega Elutia|ELUT - Target konsensus
- rincian kapitalisasi pasar:
Kapitalisasi pasar Elutia|ELUT - Total Nilai Perusahaan
- indikator kapitalisasi buku:
Nilai Buku saben Saham Elutia|ELUT - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku elutia.com|ELUT - Gunggung Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Elutia Inc.|ELUT - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Elutia Inc.|ELUT - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Elutia|ELUT - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Elutia|Rasio cepet elutia.com
- informasi bathi lan kelipatan valuasi:
ELUT - Asil keuangan resik
Analisis dhasar perusahaan:ELUT, Elutia
Produk dadi Elutia Corporation

For Elutia Inc., a developer of high-tech bio-implants, a moderate debt load is critical for maintaining the pace of innovation and preserving the trust of the medical community. By analyzing the total debt-to-equity ratio, an investor assesses the proportion of borrowed capital within the financing structure, where a decrease in this ratio minimizes default risk and enhances the business's resilience to market shocks.

Pesaing wigati

Utang marang Ekuitas Intuitive|Rasio Total Utang marang Ekuitas Danaher Corporation (DHR)|Total Utang marang Modal BDX|STE - Utang marang Modal|Total Utang marang Modal WST (West Pharmaceutical Services)|BAX: Rasio Utang marang Ekuitas|Masimo - Total Utang marang Modal|Koefisien Total Utang marang Modal Stevanato Group SpA STVN|TFX: Total Utang marang Modal|Rasio Total Utang marang Ekuitas Merit Medical Corp|NVST (Envista Holdings) - Total Utang marang Modal|Total Utang marang Modal icumed.com|Utang marang Ekuitas Dentsply Sirona (XRAY)|Utang marang Ekuitas LMAT (LeMaitre Vascular Inc)|AtriCure Corp - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi STAA|ChromaDex Corp. - Total Utang marang Modal|Koefisien Total Utang marang Modal zimvie.com ZIMV|AngioDynamics (ANGO) - Utang marang Ekuitas|Rasio Utang marang Ekuitas CERS|Utang marang Ekuitas Alpha Teknova Inc|Monogram Orthopedics Inc. (MGRM) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas STSS (Sharps Technology, Inc.)|Utang Agregat marang Modal INFU|Utang marang Ekuitas Utah Medical Products, Inc. UTMD|Rasio Kabeh Utang marang Dana Pribadi KRMD|NYXH: Rasio Total Utang marang Ekuitas|MBOT - Total Utang marang Modal|Pro-Dex, Inc. (PDEX) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas zentek.com|MLSS (Milestone Scientific Inc.) - Total Utang marang Modal|Utang marang Modal NEXGEL Inc. NXGL|Utang marang Ekuitas Retractable Technologies (RVP)|harvardbioscience.com - Rasio Utang marang Ekuitas|Femasys Inc. - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal MHUA (Meihua Medical Technologies)|POAI - Utang marang Ekuitas|Koefisien Total Utang marang Modal Callan JMB Inc CJMB|ATRI: Total Utang marang Modal|Utang marang Modal NeuroMetrix Corporation (NURO)